Screening for colorectal cancer in the UK

Digestive and Liver Disease

Volumn 38, Issue 4, 2006, Pages 279-282

  Anwar, R ^a  

^a HINCHINGBROOKE HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Faecal occult blood; Flexible sigmoidoscopy; Screening

Indexed keywords

DNA;

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; DNA DETERMINATION; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; MASS SCREENING; OCCULT BLOOD TEST; POPULATION RESEARCH; SIGMOIDOSCOPY; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

COLON; COLONOSCOPY; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FECES; GREAT BRITAIN; HUMANS; MASS SCREENING; OCCULT BLOOD; SIGMOIDOSCOPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748514993     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.01.011     Document Type: Article

References (28)

1. Guidance on cancer services-improving outcomes in colorectal cancers-manual update. London: National Institute for Clinical Excellence; 2004.
2. Morson B. Genesis of colorectal cancer. Clin Gastroenterol 5 (1976) 505-525
3. Hermanek P., and Sobin L. Prognostic factors in cancer. HCII. International Union against cancer (1995), Springer-Verlag, Berlin
4. Dukes C.E., and Bussey H.J.R. The spread of rectal cancer and its effect on prognosis. Br J Cancer 12 (1958) 309
5. Gnauch R. World Health organization's criteria for screening. In: Winawer S.J., Schorrenfeld D., and Sherlock P. (Eds). Colorectal cancer: prevention, epidemiology screening (1980), Raven Press, New York 1975-1978
6. Winawer S., Fletcher R., Miller L., Godlee F., Stolar M., Mulrow C., et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112 (1997) 594-642
7. US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 137 (2002) 129-131
8. Morrin M., and Lamont J. Screening virtual colonoscopy-ready for prime time. N Engl J Med 349 (2003) 2261-2264
9. Deenadayalu V., and Rex D. Fecal-based DNA assays: a new, noninvasive approach to colorectal cancer screening. Cleve Clin J Med 71 (2004) 497-503
10. Atkin W., and Northover J. Population based endoscopic screening for colorectal cancer. Gut 52 (2003) 321-322
11. Vining D., Gelfand D., and Bechtold R. Technical feasibility of colon imaging with helical CT and virtual reality. Am J Roentgenol 62 (1994) 1104
12. Johnson C., Harmsen W., Wilson L., Maccarty R., Welch T., Ilstrup D., et al. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. Gastroenterology 125 (2003) 311-319
13. Pickhardt P., Choi J., Hwang I., Butler J., Puckett M., Hildebrandt H., et al. Computed Tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349 (2003) 2191-2200
14. Munikrishnan V., Gillams A., Lees W., Vaizey C., and Boulos P. Prospective study comparing multislice CT colonography with colonoscopy in the detection of colorectal cancer and polyps. Dis Colon Rectum 46 (2003) 1384-1390
15. Rabeneck L. Is computed tomographic colonography effective for colorectal cancer screening?. Can Med Assoc J 170 (2004) 1392
16. Schroy P., and Heeren T. A comparative study of patient perceptions and screening preferences for stool-based DNA testing (SBDNA), fecal occult blood testing (FOBT), or colonoscopy (CS). Gastroenterology 124 (2003) 481
17. Morikawa T., Kato J., Yamaji Y., Wada R., Mitsushima T., and Shiratori Y. Immunochemical fecal occult blood testing: better than guaiac-based tests but far from perfect. Gastroenterology 129 (2005) 422-428
18. Mandel J., Bond J., Church T., Snover D., Bradley G., Schuman L., et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med 328 (1993) 1365-1371
19. Kronborg O., Fenger C., Olsen J., Jørgensen O., and Søndergaard O. A randomized study of screening for colorectal cancer with fecal occult blood test. Lancet 348 (1996) 1467-1471
20. Hardcastle J., Chamberlain J., Robinson M., Moss S., Amar S., Balfour T., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996) 1472-1477
21. Faivre J., Dancourt V., Lejeune C., Tazi M., Lamour J., Gerard D., et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 126 (2004) 1674-1680
22. Fletcher R. Screening sigmoidoscopy-how often and how good?. J Am Med Assoc 290 (2003) 106-108
23. Farraye F., and Wallace M. Clinical significance of small polyps found during screening with flexible sigmoidoscopy. Gastrointest Endosc Clin N Am 12 (2002) 41-51
24. Segnan N., Senore C., Andreoni B., Aste H., Bonelli L., Crosta C., et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"-SCORE. J Natl Cancer Inst 94 (2002) 1763-1772
25. UK Flexible Sigmoidoscpy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer; baseline findings of a UK multicenre randimised trial. Lancet 359 (2002) 1291-1300
26. Whynes D., Frew E., Edwards R., and Atkin W. Cost of flexible sigmoiscopy screening for colorectal cancer in the United Kingdom. Int J Technol Assess Health Care 19 (2003) 384-395
27. Pignone M., Saha S., Hoeger T., and Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Ann Intern Med 137 (2002) 96-104
28. Wagner J., Tunis S., Brown M., Ching A., and Almeida R. Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young G., and Levin B. (Eds). Prevention and early detection of colorectal cancer (1996), Saunders, London